Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Weight Loss 2Carcinoma, Non-Small-Cell Lung 2Cachexia 2Anorexia 2Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1

Interventions

Megestrol Acetate 11Mirtazapine 5Olanzapine 4anamorelin 2Infliximab 2nabiximols 1nabilone 1Watchful Waiting 1Thalidomide 1Surveys and Questionnaires 1Sugars 1Radiotherapy 1Quality of Life 1Palonosetron 1Observation 1Nicotine 1Modafinil 1Minocycline 1Melatonin 1Megestrol 1Magnetic Resonance Spectroscopy 1Gemcitabine 1Flurandrenolone 1Etanercept 1Eicosapentaenoic Acid 1EOM613 1Dronabinol 1Docetaxel 1Dexamethasone 1Creatine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anorexia × anamorelin × Clear all
NCT03637816 2026-04-15

Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer

M.D. Anderson Cancer Center

Phase 2/3 Active not recruiting
25 enrolled
Thoracic

Anorexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04844970 2025-11-17

Anamorelin Study for Advanced Pancreatic Cancer

Lahey Clinic

Phase 2 Terminated
4 enrolled 12 charts
Gastrointestinal

Anorexia, Cachexia, Pancreatic Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡